TY - JOUR
T1 - Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors
AU - Martínez, Leandro
AU - Sonoda, Milton T.
AU - Webb, Paul
AU - Baxter, John D.
AU - Skaf, Munir S.
AU - Polikarpov, Igor
N1 - Funding Information:
We thank Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, grants 99/03387-4 to I.P. and 03/09361-4 to M.S.S.), the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, grant 401913/2003-1 to M.S.S.), the Coordenação de Aperfeiçoamento de Pessoal do Nível Superior (CAPES), and the National Institutes of Health (DK41482, DK51281, and DK64148 to J.D.B.) for financial support. J.D.B. has proprietary interests in and serves as a consultant and deputy director to Karo Bio AB, which has commercial interests in this area of research.
PY - 2005/9
Y1 - 2005/9
N2 - Nuclear receptor (NR) ligands occupy a pocket that lies within the core of the NR ligand-binding domain (LBD), and most NR LBDs lack obvious entry/exit routes upon the protein surface. Thus, significant NR conformational rearrangements must accompany ligand binding and release. The precise nature of these processes, however, remains poorly understood. Here, we utilize locally enhanced sampling (LES) molecular dynamics computer simulations to predict molecular motions of x-ray structures of thyroid hormone receptor (TR) LBDs and determine events that permit ligand escape. We find that the natural ligand 3,5,3′-triiodo-L-thyronine (T3) dissociates from the TRα1 LBD along three competing pathways generated through i), opening of helix (H) 12; ii), separation of H8 and H11 and the Ω-loop between H2 and H3; and iii), opening of H2 and H3, and the intervening β-strand. Similar pathways are involved in dissociation of T3 and the TRβ-selective ligand GC24 from TRβ; the TR agonist IH5 from the α- and β-TR forms; and Triac from two natural human TRβ mutants, A317T and A234T, but are detected with different frequencies in simulations performed with the different structures. Path I was previously suggested to represent a major pathway for NR ligand dissociation. We propose here that Paths II and III are also likely ligand escape routes for TRs and other NRs. We also propose that different escape paths are preferred in different situations, implying that it will be possible to design NR ligands that only associate stably with their cognate receptors in specific cellular contexts.
AB - Nuclear receptor (NR) ligands occupy a pocket that lies within the core of the NR ligand-binding domain (LBD), and most NR LBDs lack obvious entry/exit routes upon the protein surface. Thus, significant NR conformational rearrangements must accompany ligand binding and release. The precise nature of these processes, however, remains poorly understood. Here, we utilize locally enhanced sampling (LES) molecular dynamics computer simulations to predict molecular motions of x-ray structures of thyroid hormone receptor (TR) LBDs and determine events that permit ligand escape. We find that the natural ligand 3,5,3′-triiodo-L-thyronine (T3) dissociates from the TRα1 LBD along three competing pathways generated through i), opening of helix (H) 12; ii), separation of H8 and H11 and the Ω-loop between H2 and H3; and iii), opening of H2 and H3, and the intervening β-strand. Similar pathways are involved in dissociation of T3 and the TRβ-selective ligand GC24 from TRβ; the TR agonist IH5 from the α- and β-TR forms; and Triac from two natural human TRβ mutants, A317T and A234T, but are detected with different frequencies in simulations performed with the different structures. Path I was previously suggested to represent a major pathway for NR ligand dissociation. We propose here that Paths II and III are also likely ligand escape routes for TRs and other NRs. We also propose that different escape paths are preferred in different situations, implying that it will be possible to design NR ligands that only associate stably with their cognate receptors in specific cellular contexts.
UR - http://www.scopus.com/inward/record.url?scp=24144439756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=24144439756&partnerID=8YFLogxK
U2 - 10.1529/biophysj.105.063818
DO - 10.1529/biophysj.105.063818
M3 - Article
C2 - 15980170
AN - SCOPUS:24144439756
SN - 0006-3495
VL - 89
SP - 2011
EP - 2023
JO - Biophysical Journal
JF - Biophysical Journal
IS - 3
ER -